Global Colorectal Cancer Therapeutics Market 2019-2023

Global Colorectal Cancer Therapeutics Market 2019-2023

About this market

The global colorectal cancer therapeutics market is largely dominated by monotherapy drugs, including targeted therapies and immunotherapies. However, the combination of these monotherapy drugs with chemotherapy or other therapeutics also increases the therapeutic value. The combination of drugs helps in overcoming the limitations of each therapeutic and increases the overall outcome in the treatment of colorectal cancer. Furthermore, the combination of therapies with or without surgery can be used to reduce the spreading of the disease and temporarily shrink a cancerous tumor. Moreover, the combination therapy that contains two or more number of therapeutics is useful to achieve an additive or synergistic effect with low doses of combinational therapeutics. Technavio’s analysts have predicted that the colorectal cancer therapeutics market will register a CAGR of almost 3% by 2023.

Market Overview

Rising population with risk factors of colorectal cancer

The incidence of colorectal cancer is increasing owing to the risk factors such as the increasing geriatric population, inflammatory diseases, genetic syndromes, and changes in lifestyle. Hence, an increase in the number of patients with these risk factors is expected to increase the development of colorectal cancer. This, in turn, is expected to aid in the use of available therapeutics, which will drive the growth of the global colorectal cancer therapeutics market during the forecast period.

Patent expiration of novel therapeutics

The pharmaceutical companies sell their innovator products, especially biologics, at a high price until their patent expiration. The expiration of patents and other intellectual property rights of therapeutics are likely to hamper the growth of the global colorectal cancer therapeutics market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the colorectal cancer therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Colorectal Cancer Therapeutics Market 2019-2023

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the development of small molecules kinase inhibitors.”

According to the report, one of the major drivers for this market is the rising population with risk factors of colorectal cancer.

Further, the report states that one of the major factors hindering the growth of this market is the side effects associated with availability medicines.

Companies Mentioned

Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co. Inc.
Sanofi

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global oncology therapeutics market
      • Table Segments of global oncology therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Targeted therapy - Market size and forecast 2018-2023
      • Table Targeted therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Targeted therapy - Year-over-year growth 2019-2023 (%)
      • Table Targeted therapies in Phase III for colorectal cancer treatment
    • Immunotherapy - Market size and forecast 2018-2023
      • Table Immunotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Immunotherapy - Year-over-year growth 2019-2023 (%)
    • Chemotherapy - Market size and forecast 2018-2023
      • Table Chemotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Chemotherapy - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table Colorectal cancer rate based on gender in US 2015
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Rate of colorectal cancer by age in the US
      • Table Global geriatric population
      • Table Combination therapies for colorectal cancer treatment
      • Table Late-stage combination therapies for treatment of colorectal cancer
    • Market challenges
      • Table Estimated patent expiry dates of a few therapeutics used for colorectal cancer treatment
      • Table Impact of drivers and challenges
  • Market trends
    • Table Some of the kinase inhibitors under development for colorectal cancer treatment
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Company
      • Table Bristol-Myers Squibb Company - Vendor overview
      • Table Bristol-Myers Squibb Company - Business segments
      • Table Bristol-Myers Squibb Company - Organizational developments
      • Table Bristol-Myers Squibb Company - Geographic focus
      • Table Bristol-Myers Squibb Company - Key offerings
      • Table Bristol-Myers Squibb Company - Key customers
    • Eli Lilly and Company
      • Table Eli Lilly and Company - Vendor overview
      • Table Eli Lilly and Company - Business segments
      • Table Eli Lilly and Company - Organizational developments
      • Table Eli Lilly and Company - Geographic focus
      • Table Eli Lilly and Company - Segment focus
      • Table Eli Lilly and Company - Key offerings
      • Table Eli Lilly and Company - Key customers
    • F. Hoffmann-La Roche Ltd
      • Table F. Hoffmann-La Roche Ltd - Vendor overview
      • Table F. Hoffmann-La Roche Ltd - Business segments
      • Table F. Hoffmann-La Roche Ltd - Organizational developments
      • Table F. Hoffmann-La Roche Ltd - Geographic focus
      • Table F. Hoffmann-La Roche Ltd - Segment focus
      • Table F. Hoffmann-La Roche Ltd - Key offerings
      • Table F. Hoffmann-La Roche Ltd - Key customers
    • Merck & Co., Inc.
      • Table Merck & Co., Inc. - Vendor overview
      • Table Merck & Co., Inc. - Business segments
      • Table Merck & Co., Inc. - Organizational developments
      • Table Merck & Co., Inc. - Geographic focus
      • Table Merck & Co., Inc. - Segment focus
      • Table Merck & Co., Inc. - Key offerings
      • Table Merck & Co., Inc. - Key customers
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
      • Table Sanofi - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook